Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program

Vaccine

Volumn 29, Issue 47, 2011, Pages 8580-8584

  Tanuseputro, Peter ^a,b,c   Zagorski, Brandon ^a   Chan, Kevin J ^c   Kwong, Jeffrey C ^a,b,c  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Canada; Chickenpox vaccine; Health services; Herpes zoster; Hospitalization; Immunization programs

Indexed keywords

CHICKENPOX VACCINE; VARICELLA ZOSTER VACCINE;

ADOLESCENT; ADULT; ARTICLE; CANADA; CHICKENPOX; CHILD; FEMALE; HEALTH CARE UTILIZATION; HERPES ZOSTER; HOSPITALIZATION; HUMAN; IMMUNIZATION; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; VACCINATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; HERPES ZOSTER; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; ONTARIO; VACCINATION; YOUNG ADULT;

EID: 82455175304     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.09.024     Document Type: Article

References (26)

1. Oxman M.N., Levin M.J., Johnson G.R., Schmader K.E., Straus S.E., Gelb L.D., et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005, 352(22):2271-2284.
2. Merck Frosst Press Release: Zostavax™. Report 2009, Merck Frosst Canada Ltd.
3. Seward J.F., Watson B.M., Peterson C.L., Mascola L., Pelosi J.W., Zhang J.X., et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002, 287(5):606-611.
4. Centers for Disease Control and Prevention (CDC) Decline in annual incidence of varicella - selected states, 1990-2001. MMWR Morb Mortal Wkly Rep 2003, 52(37):884-885.
5. Nguyen H.Q., Jumaan A.O., Seward J.F. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 2005, 352(5):450-458.
6. Davis M.M., Patel M.S., Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 2004, 114(3):786-792.
7. Zhou F., Harpaz R., Jumaan A.O., Winston C.A., Shefer A. Impact of varicella vaccination on health care utilization. JAMA 2005, 294(7):797-802.
8. Kwong J.C., Tanuseputro P., Zagorski B., Moineddin R., Chan K.J. Impact of varicella vaccination on health care outcomes in Ontario, Canada: effect of a publicly funded program?. Vaccine 2008, 26(47):6006-6012.
9. Brisson M., Edmunds W.J. The cost-effectiveness of varicella vaccination in Canada. Vaccine 2002, 20(7-8):1113-1125.
10. Brisson M., Edmunds W.J., Gay N.J., Miller E. Varicella vaccine and shingles. JAMA 2002, 287(17):2211-2212.
11. Edmunds W.J., Brisson M. The effect of vaccination on the epidemiology of varicella zoster virus. J Infect 2002, 44(4):211-219.
12. Brisson M., Edmunds W.J., Gay N.J. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J Med Virol 2003, 70(Suppl. 1):S31-S37.
13. Jumaan A.O., Yu O., Jackson L.A., Bohlke K., Galil K., Seward J.F. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis 2005, (12):2002-2007.
14. Mullooly J.P, Riedlinger K., Chun C., Weinmann S., Houston H. Incidence of herpes zoster, 1997-2002. Epidemiol Infect 2005, 133(2):245-253.
15. Reynolds M.A., Chaves S.S., Harpaz R., Lopez A.S., Seward J.F. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review. J Infect Dis 2008, 197(Suppl2):S224-S227.
16. Yih W.K., Brooks D.R., Lett S.M., Jumaan A.O., Zhang Z., Clements K.M., et al. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health 2005, 5:68.
17. Carville K.S., Riddell M.A., Kelly H.A. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia. Vaccine 2010, 28(13):2532-2538.
18. Chan B.T.B., Schultz S.E. Supply and Utilization of General Practitioner and Family Physician Services in Ontario. ICES Investigative Report 2005, Institute for Clinical Evaluative Sciences, Toronto.
19. Gil A., Gil R., Alvaro A., San Martin M., Gonzalez A. Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998-2004). BMC Infect Dis 2009, 9:55.
20. Patel M.S., Gebremariam A., Davis M.M. Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States. Infect Control Hosp Epidemiol 2008, 29(12):1157-1163.
21. Russell M.L., Schopflocher D.P., Svenson L., Virani S.N. Secular trends in the epidemiology of shingles in Alberta. Epidemiol Infect 2007, 135(6):908-913.
22. Brisson M., Edmunds W.J., Law B., Gay N.J., Walld R., Brownell M., et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 2001, 127(2):305-311.
23. Edgar B.L., Galanis E., Kay C., Skowronski D., Naus M., Patrick D. The burden of varicella and zoster in British Columbia 1994-2003: baseline assessment prior to universal vaccination. Can Commun Dis Rep 2007, 33(11):1-15.
24. Insinga R.P., Itzler R.F., Pellissier J.M., Saddier P., Nikas A.A. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 2005, 20(8):748-753.
25. Opstelten W., van Loon A.M., Schuller M., van Wijck A.J., van Essen G.A., Moons K.G., et al. Clinical diagnosis of herpes zoster in family practice. Ann Fam Med 2007, 5(4):305-309.
26. Chien A.J., Olerud J.E. Why do so many clinicians believe that recurrent zoster is common?. Dermatol Online J 2007, 13(2):2.